Number of fitness-to-practise cases open for more than a year increases to 430 cases, regulator tells MP The number of cases open for more than three years rose to 77 cases in 2022/2023, up from 49 cases in 2021/2022.…
Asian and black pharmacists overrepresented in fitness-to-practise concerns, GPhC finds The General Pharmaceutical Council has analysed data on fitness-to-practise concerns and found that all ethnicities other than white pharmacists were overrepresented.…
PSA writes to health secretary to ‘raise concerns’ over GPhC’s fitness-to-practise timeliness Duncan Rudkin, chief executive of the GPhC, said it was “an absolute priority” for it to resolve fitness-to-practise cases “in a timely way”.…
GPhC facing biggest ever backlog of open fitness-to-practise cases at initial assessment stage Council papers said there were more than 700 open initial assessment fitness-to-practise cases.…
Pharmacist given warning as committee in second fitness-to-practise case rules remarks were antisemitic The General Pharmaceutical Council’s fitness-to-practise committee issued Nazim Hussain Ali with a warning for a second time over remarks he made at an Al Quds Day rally, after its initial decision was quashed by the High Court.…
Community pharmacy supervision does not mean overseeing ‘individual transactions’, pharmacy bodies determine The cross-sector group of seven pharmacy sector organisations says public, primary and secondary legislation should be updated to reflect its supervision recommendations.…
Regulator reports 50% increase in early closures of fitness-to-practise cases General Pharmaceutical Council papers show that 69 cases were closed before the investigating committee stage in January to March 2023, compared with 46 cases in the previous quarter.…
CQC says it is reviewing concerns about major homecare medicines provider A spokesperson for the regulator said inspectors are currently reviewing concerns raised about Sciensus and will determine whether regulatory action is required.…
European regulator finds at least 20 medicines with significant nitrosamine contamination Exclusive: The European Medicines Agency has said products identified as containing nitrosamine above acceptable levels will likely require a variation in their marketing authorisation.…
Employers should take ‘challenging situations’ into account if complaints are made about pharmacy staff this winter The General Pharmaceutical Council and UK chief pharmaceutical officers have written to pharmacy teams to reassure them as the NHS faces huge pressures.…
